Erratum: MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting akt (PLoS ONE (2015) 9:12 (e115980) DOI: 10.1371/journal.pone.0115980);MicroRNA-302a functions as a putative tumor suppressor in colon cancer by targeting Akt

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Sun, Shengjie ^a   Zhang, Guoqing ^a   Wu, Zhiyong ^a   Shi, Weiwei ^a   Yang, Bo ^a   Li, Ying ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MICRORNA; MICRORNA 302A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLON; COLON CANCER; CONTROLLED STUDY; DOWNSTREAM PROCESSING; G1 PHASE CELL CYCLE CHECKPOINT; GENE TARGETING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE AGED; PROTEIN TARGETING; S PHASE CELL CYCLE CHECKPOINT;

EID: 84919884410     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139497     Document Type: Erratum

References (21)

1. Chen W, Zheng R, Zhang S, Zhao P, Li G, et al. (2013) Report of incidence and mortality in China cancer registries, 2009. Chin J Cancer Res 25: 10-21.
2. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
3. Fidler IJ (1990) Critical factors in the biology of human cancer metastasis: 28th G. H. A. Clowes Memorial Award Lecture. Cancer Res 50: 6130-6138.
4. Chang GJ, Kaiser AM, Mills S, Rafferty JF, Buie WD (2012) Practice parameters for the management of colon cancer. Dis Colon Rectum 55: 831-843.
5. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
6. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Can 6: 259-269.
7. Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, et al. (2013) MicroRNA-302 increases reprogramming efficiency via repression of NR2F2. Stem Cells (Dayton, Ohio) 31: 259-268.
8. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, et al. (2008) Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 28: 6426-6438.
9. Fareh M, Turchi L, Virolle V, Debruyne D, Almairac F, et al. (2012) The miR 302-367 cluster drastically affects self-renewal and infiltration properties of glioma-initiating cells through CXCR4 repression and consequent disruption of the SHH-GLI-NANOG network. Cell Death Differentiation 19: 232-244.
10. Cai N, Wang YD, Zheng PS (2013) The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1. RNA (New York, N.Y.) 19: 85-95.
11. Zhu R, Yang Y, Tian Y, Bai J, Zhang X, et al. (2012) Ascl2 knockdown results in tumor growth arrest by miRNA-302b-related inhibition of colon cancer progenitor cells. PLOS ONE 7: e32170.
12. Huang JX, Shen SL, Lin M, Xiao W, Chen WC, et al. (2012) Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma. Onc Lett 4: 607-611.
13. Lin SL, Chang DC, Ying SY, Leu D, Wu DT (2010) MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res 70: 9473-9482.
14. Wang L, Yao J, Shi X, Hu L, Li Z, et al. (2013) MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer 13: 448.
15. Bourguignon LY, Wong G, Earle C, Chen L (2012) Hyaluronan-CD44v3 interaction with Oct4-Sox2- Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287: 32800-32824.
16. Toker A, Marmiroli S (2014) Signaling specificity in the Akt pathway in biology and disease. Advances in Biological Regulation.
17. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
18. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, et al. (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67: 2456-2468.
19. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nature Genetics 39: 673-677.
20. Liang Z, Ahn J, Guo D, Votaw JR, Shim H (2013) MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation. Pharmaceutical Research 30: 1008-1016.
21. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, et al. (2008) The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7: 759-764.